Business Description

Baxter International Inc. provides a variety of healthcare products. Baxter International Inc. was founded in 1931. It is located in Deerfield, Illinois. It is available in North and South America, Europe, the Middle East, Africa, and Asia-Pacific. It offers hemodialysis, peritoneal and other dialysis treatments. It offers biological products, medical products, and surgical hemostats. These products can be used for tissue sealing and surgery for hemostasis. Products from the company can be found in hospitals and dialysis centers, doctor’s offices, nursing homes, and patients at home. The company sells its products through a direct sales force, independent distributors, and drug wholesalers. Celerity Pharmaceutical, LLC has agreed to develop generic injectable premixes for acute and oncolytic care.

Key Financials

Revenue (US$ Mn):

• Baxter International Inc.’s annual revenue for 2021 was US$ 12,784 Mn, a 9.52% increase from 2020
• The annual revenue generated by Baxter International Inc. in 2020 was US$ 11,673 Mn
• At a 2.11% increase from , Baxter International Inc.’s annual revenue of US$ 11,362 Mn was indexed in 2019
• Baxter International Inc. generated total revenue of US$ 11,127 Mn in 2018

Operating Income (US$ Mn):

• US$ 1,710 Mn was the operating income generated by Baxter International Inc. in 2021
• Baxter International Inc.’s operating income for 2020 was US$ 1,616 Mn, a -8.8% decrease from 2019
• From 2018’s operating incomes, Baxter International Inc. registered a 10.82% increase in 2019, amounting to US$ 1,772 Mn
• An operating income of US$ 1,599 Mn was generated in 2018 by Baxter International Inc.

Net Income (US$ Mn):

• Baxter International Inc.’s net income for 2021 was US$ 1,284 Mn, a 16.52% increase from 2020
• The net income generated by Baxter International Inc. in 2020 was US$ 1,102 Mn
• At a -38.36% decrease from , Baxter International Inc.’s net income of US$ 1,001 Mn was indexed in 2019
• Baxter International Inc. generated a net income of US$ 1,624 Mn in 2018

Operating Margin %:

• Baxter International Inc.’s operating margin for 2021 was 13%, a -3.62% decrease from 2020
• The operating margin generated by Baxter International Inc. in 2020 was 14%
• At a 7.64% increase from , Baxter International Inc.’s operating margin of 16% was indexed in 2019
• Baxter International Inc. generated an operating margin of 14% in 2018

Gross Margin %:

• 40% was the gross margin generated by Baxter International Inc. in 2021
• Baxter International Inc.’s gross margin for 2020 was 39%, a -6.44% decrease from 2019
• From 2018’s gross margins, Baxter International Inc. registered a -2.56% decrease in 2019, amounting to 42%
• A gross margin of 43% was generated in 2018 by Baxter International Inc.

SWOT Analysis

Strengths

R&D

Baxter is involved with research and development (R&D) to ensure that the company remains competitive in the market. This includes product development. There are R&D centers in China, Belgium, Germany, Germany, and the USA. In FY2017, the company invested US$617million in R&D. This was 5.8%. This gives the company a competitive advantage over its peers and long-term operational stability.

Get this premium content

The Premium data is Locked

Buy Now to Unlock Premium Data

Request Sample Data